Tamara Al-Zubeidi, B.S.

Clarivate
London, England, United Kingdom

Disclosure information not submitted.

Presentation(s):

• MON-727 - Participant-Reported Weight Reduction and Reasons for Continuing or Discontinuing Tirzepatide Treatment: Insights from the PERCEPTIONS Longitudinal Survey at 3 Months

  Monday, June 15, 2026
  9:00 AM - 2:00 PM CT